Bacterial endotoxins and exotoxins (None)

Bacterial toxins are potent virulence factors produced by bacteria to facilitate infection and survival within a host (StatPearls, 2023). Endotoxins, primarily lipopolysaccharides (LPS) found in the outer membrane of Gram-negative bacteria, trigger robust inflammatory responses by activating the TLR4 signaling pathway, which can lead to clinical complications such as sepsis and septic shock (NIH, 2022). In contrast, exotoxins are secreted proteins that exert specific toxic effects, such as disrupting cell membranes, inhibiting protein synthesis, or interfering with nerve signaling (Wikipedia, 2024). Therapeutic strategies targeting these toxins include the use of neutralizing antibodies like bezlotoxumab and raxibacumab, which prevent the toxin from binding to host receptors (FDA, 2024). Additionally, small molecules like polymyxin B can be used to bind and sequester endotoxins directly to prevent immune overactivation (PubChem, 2024). Managing toxin-mediated diseases is critical in treating conditions like diphtheria, anthrax, and Clostridioides difficile infections (CDC, 2023).

Other names

Bacterial toxinsMicrobial toxinsLPS and secreted toxinsPyrogens

The primary mechanism of action for drugs targeting bacterial toxins is direct neutralization or sequestration. For exotoxins, monoclonal antibodies bind to specific epitopes on the toxin protein, sterically hindering its ability to interact with host cell surfaces or enter cells (FDA, 2024). For endotoxins, certain agents like polymyxin B bind to the lipid A moiety of the lipopolysaccharide molecule, neutralizing its ability to trigger the TLR4/MD2 receptor complex on immune cells (StatPearls, 2023). Additionally, toxoid vaccines utilize inactivated toxins to stimulate the production of endogenous neutralizing antibodies (CDC, 2023).